Acarbose (Alvogen, Inc.)
Welcome to the PulseAid listing for the Acarbose drug offered from Alvogen, Inc.. This alpha Glucosidase Inhibitors [MoA],alpha-Glucosidase Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Alvogen, Inc. |
NON-PROPRIETARY NAME: | acarbose |
SUBSTANCE NAME: | ACARBOSE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | alpha Glucosidase Inhibitors [MoA],alpha-Glucosidase Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2008-01-30 |
END MARKETING DATE: | 0000-00-00 |
Acarbose HUMAN PRESCRIPTION DRUG Details:
Item Description | Acarbose from Alvogen, Inc. |
LABELER NAME: | Alvogen, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 25(mg/1) |
START MARKETING DATE: | 2008-01-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 47781-340_6b3a1576-6f9a-4dd3-b5f7-794c81ce335a |
PRODUCT NDC: | 47781-340 |
APPLICATION NUMBER: | NDA020482 |
Other ACARBOSE Pharmaceutical Manufacturers / Labelers: